Research and development projects being realized and recently completed at BioMat - Applied Radiation Chemistry group
Treść (rozbudowana)
H2020 - OPTOGENERAPY
OPTOGENETIC PROTEIN THERAPY FOR MULTIPLE SCLEROSIS
(Optogenetyczna terapia białkowa do leczenia stwardnienia rozsianego)
Optogenerapy project addresses the urgent clinical need for safe cell-based protein delivery therapies. The main objective is to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN-ß) protein delivery for treating patients suffering from multiple sclerosis
see more about the Optogenerapy project
H2020-NMBP-2016-720694-2
Project leader: Radosław Wach
0
projekt2
bbbbb
Image
0